SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant momentum driven by a newly announced collaboration with NVIDIA to integrate its QNX safety-critical OS into advanced edge AI systems, fueling a community-led surge in retail interest and trending status. Investors are increasingly optimistic about the companys turnaround, pointing to growing royalty backlogs, cybersecurity demand, and the stock's recent break past key resistance levels as signs of a long-awaited revaluation.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a sharp rally following a rapid management response to a short-seller report, which included plans to redomicile in the U.S. and clarify tax status regarding PFIC concerns. The community is actively discussing a potential short squeeze, highlighting strong institutional accumulation and the stock's positioning within the high-demand AI data center infrastructure sector.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing a surge in trading volume and bullish sentiment driven by clinical trial progress, including favorable updates on their prostate cancer treatment that have stoked speculation about potential partnership or buyout interest. The community is actively discussing the stock's undervaluation compared to its large market potential, with many investors pointing to recent institutional accumulation and the expectation of upcoming regulatory milestones as catalysts for a potential short squeeze.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing massive retail and institutional attention following a new executive order that fast-tracks regulatory pathways and funding for psychedelic drug research, specifically highlighting ibogaine. The community is actively debating the stock's potential for a short squeeze driven by its extremely low tradable float, while some investors urge caution regarding potential dilution and the long-term reality of clinical timelines.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is experiencing heightened investor interest and increased volume following a definitive agreement to acquire Serra Verde Group for approximately $2.8 billion, a move described by the community as a major strategic pivot to secure non-Asian supply chain dominance. While some market participants are debating the short-term impacts of the associated share dilution, sentiment remains largely focused on the potential for long-term supply chain leverage and the stock's role in the broader shift toward domestic critical mineral independence.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI Life Sciences N.V.

ATAI is trending as investors react to a potential $2 billion buyout process for its lead BPL-003 asset and excitement surrounding the company's Q2 Phase 3 trial initiation. The community is actively discussing the stock's long-term potential as a psychedelic platform, with many highlighting its institutional backing and the significant regulatory tailwinds shifting the sector's outlook.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi is seeing significant volatility as investors react to a sudden leadership shakeup involving the resignation of the CEO and CFO, alongside ongoing concerns about delayed power milestones and the search for an anchor tenant. While some community members are treating the pullback as a buying opportunity given the project's long-term scale and infrastructure potential, others are increasingly skeptical, pointing to the lack of revenue and the potential for further downside before stabilization.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently surging as investors react to positive regulatory shifts regarding peptide distribution and a strengthening partnership narrative with Novo Nordisk. The community is actively discussing a potential short squeeze, with many participants highlighting the stock's high short interest and expressing bullish sentiment about the company's long-term growth as it pivots toward a broader health and wellness ecosystem.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant volatility following a failed orbital deployment of a satellite by Blue Origin, leading to intense community debate over execution risks versus the company's long-term growth thesis. While some investors are viewing the price drop as a strategic buying opportunity supported by insurance coverage and a robust production pipeline, others remain critical of the company's reliance on external launch providers and the resulting timeline delays.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is experiencing high volatility and significant momentum as investors anticipate imminent Phase 3 clinical trial results for its psilocybin-based treatment, COMP360. The community is closely debating the clinical trial data readout and the stock's potential as a takeover candidate, with many traders closely watching for price breakouts tied to regulatory tailwinds and speculative short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Digimarc (NASDAQ:DMRC) Price Target Cut to $10.00 by Analysts at Needham & Company LLC

Needham & Company LLC reduced their price target on shares of Digimarc from $20.00 to $10.00 and set a "buy" rating on the stock in a report on Monday...

Digimarc (NASDAQ:DMRC) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Digimarc from a "sell" rating to a "hold" rating in a research note on Saturday...

Digimarc (NASDAQ:DMRC) Releases Quarterly Earnings Results, Beats Estimates By $0.07 EPS

Digimarc (NASDAQ:DMRC - Get Free Report) posted its earnings results on Wednesday. The information technology services provider reported $0.05 EPS for the quarter, beating analysts' consensus...

Digimarc Sets Q4 2025 Earnings Q&A Supplemental Call for March 16, 2026

Digimarc Corporation (NASDAQ: DMRC), a leading provider in digital identity and authentication solutions, will hold a Q&A session with investors on March 16, 2026 at 5 p.m. Eastern time (2 p.m...

<ul class="summary-bullets"><li>The company swung to profit in Q4 and reported earnings per share of $0.05 versus year-ago loss per share of $0.22.</li><li>Adjusted operating expenses for the fourth quarter of 2025 were $6.5 million compared to $11.9 million for the fourth quarter of 2024.</li><li>On Stocktwits, retail sentiment around DMRC&nbsp;stock trended in ‘extremely bullish’ territory amid ‘high’ message volume.&nbsp;</li></ul><p>DigiMarc (DMRC) shares rallied 7% during extended hours of trading after it reported a&nbsp;higher-than-expected&nbsp;fourth-quarter (Q4) revenue on Wednesday.&nbsp;</p><p>DMRC’s total revenue for Q4 2025 was $8.9 million compared to $8.7 million for the fourth quarter of 2024. Analysts on average expected $8.2 million in revenue, as per data from&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://fiscal.ai">Fiscal.ai</a>.&nbsp;</p><h2 class="st-heading-2">Q4 Snapshot</h2><p>DigiMarc’s subscription revenue for Q4 2025 came at $5.3 million compared to $5.0 million for the fourth quarter of 2024. The increase reflects $1.4 million of patent license fees earned during the quarter and higher subscription revenue from new and existing commercial contracts, partially offset by a $1.4 million decrease relating to the expiration of two previously disclosed commercial contracts in 2025,&nbsp;the company said.</p><p>The company's adjusted net income for Q4 2025 was $1.0 million or $0.05 per diluted share compared to adjusted net loss of $4.6 million or $0.22 per diluted share for the fourth quarter of 2024.</p><p>“Digimarc is capitalizing on the convergence of key trends driving increased demand for our solutions, positioning ourselves to benefit from - not be the casualty of - the relentless advance of AI," said Riley McCormack, Digimarc CEO. "In Q4 2025, we achieved both positive non-GAAP net income and positive free cash flow. Looking ahead to 2026, we expect to generate significant ARR growth."</p><h2 class="st-heading-2">Expenses Come Down</h2><p>Operating expenses for the quarter were $10.0 million, compared to $14.4 million for Q4 2024.&nbsp;</p><p>The decrease was led by lower cash compensation costs of $4.4 million, largely due to lower headcount, and lower professional services costs of $0.6 million, partially offset by higher stock compensation costs of $0.7 million.&nbsp;</p><p>Adjusted operating expenses for the quarter were $6.5 million compared to $11.9 million for Q4 2024.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>Retail sentiment around DMRC&nbsp;stock trended in ‘extremely bullish’ territory amid ‘high’ message volume.&nbsp;</p><p>Shares in the company have fallen 9.4% so far in 2026.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

On Stocktwits, retail sentiment around DMRC stock trended in ‘extremely bullish’ territory amid ‘high’ message volume. 

DigiMarc Stock Rallies After Hours On Q4 Revenue Beat

DMRC’s total revenue for the fourth quarter of 2025 was $8.9 million compared to $8.7 million for the fourth quarter of 2024.

Equity

DMRC’s total revenue for the fourth quarter of 2025 was $8.9 million compared to $8.7 million for the fourth quarter of 2024.


Digimarc Q4 Earnings Call Highlights

Digimarc (NASDAQ:DMRC) executives used the company's fourth-quarter earnings call to highlight progress on its Secure Gift Card initiative, continued growth in product authentication, and expanding...

Digimarc Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Digimarc Corporation (NASDAQ: DMRC) reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Digimarc is capitalizing on the convergence of key trends driving...

Costco takes big step to fix one of members' biggest complaints

As a 20-year Costco member, there are clearly many things I love about the store. If I didn't, I wouldn't keep paying a membership fee year after year.Some of my favorite Costco membership perks are...

Digimarc Sets Fourth Quarter 2025 Conference Call for Wednesday, March 11

Digimarc Corporation (NASDAQ: DMRC), a leading provider in digital identity and authentication solutions, will hold a conference call on Wednesday, March 11, 2026, at 5 p.m. Eastern time (2 p.m...

Digimarc (DMRC) to Release Quarterly Earnings on Wednesday

Digimarc (NASDAQ:DMRC) will be releasing earnings before the market opens on Wednesday, February 25. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-2-25-digimarc-co-stock...

Digimarc Corp. provides digital watermarking technology services. It develops solutions, licenses intellectual property, and provides development services. The company also connects print, audio, and packaging to brand-defined online content, protects, identifies, and tracks digital files, and confirms content and objects are genuine, unaltered, and from an authorized source. Its products include Digimarc Validate, Digimarc Engage, Digimarc Recycle and Digimarc Retail Experience. The company was founded on January 3, 1995 and is headquartered in Beaverton, OR.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.36	--	--	N/A
Q4 '25	-$0.24	-$0.19	20.83%	BEAT
Q3 '25	-$0.23	-$0.38	-65.22%	MISSED
Q2 '25	-$0.31	-$0.38	-20.63%	MISSED
Q1 '25	-$0.47	-$0.55	-17.02%	MISSED

DMRC
Digimarc Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest DMRC News

DMRCDigimarc Corporation